Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

Sinovac Biotech Ltd Dismisses UK Private Equity’s Nominal Share Acquisition Offer

October 27, 2024
CompanyDrug

Beijing Aosaikang Initiates Phase III Trial for Advanced Gastric Cancer Treatment

October 27, 2024
CompanyDeals

Zhejiang Dian Diagnostics Partners with Gulf Medical University for Middle East Expansion

October 27, 2024
CompanyDrug

FDA Approves Casgevy, the First CRISPR-Based Gene Editing Therapy for β-Thalassemia

October 27, 2024
R&D

Sun Yat-sen University Researchers Develop AI Model for Early Ovarian Cancer Detection

October 27, 2024
CompanyDrug

Shanghai-Based NK CellTech Earns FDA IND Clearance for Non-Genetically Modified NK Cell Therapy

October 27, 2024
Policy / Regulatory

Hainan Province Unveils Measures to Support Innovative Drugs and Medical Devices Development

October 27, 2024
Legal / IPPolicy / Regulatory

Shanghai Medical Products Administration Issues Trial Measures for Pharmaceutical Quality and Safety Personnel

October 27, 2024
CompanyLegal / IP

USPTO Invalidates Key Seagen-Held Patent in ADC Conjugation Dispute with Daiichi Sankyo

October 27, 2024
Company

Bayer Unveils New Operating Model to Drive Profitable Growth Amid Challenges

October 27, 2024
CompanyDrug

Eisai and Medivir’s Combo Therapy Advances in Liver Cancer with Positive Trial Results

October 27, 2024
Legal / IPPolicy / Regulatory

Shanghai Enhances Biomedicine IP Protection with New Procurement-Linked Measures

February 2, 2025
1 2 … 10 11 12 13 14 … 27 28
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up